Prediction of anticancer property of bowsellic acid derivatives by quantitative structure activity relationship analysis and molecular docking study

Abstract

Context:Boswellic acid consists of a series of pentacyclic triterpene molecules that are produced by the plant Boswellia serrata. The potential applications of Bowsellic acid for treatment of cancer have been focused here.Aims:To predict the property of the bowsellic acid derivatives as anticancer compounds by various computational approaches.Materials and Methods:In this work, all total 65 derivatives of bowsellic acids from the PubChem database were considered for the study. After energy minimization of the ligands various types of molecular descriptors were computed and corresponding two-dimensional quantitative structure activity relationship (QSAR) models were obtained by taking Andrews coefficient as the dependent variable.Statistical Analysis Used:Different types of comparative analysis were used for QSAR study are multiple linear regression, partial least squares, support vector machines and artificial neural network.Results:From the study geometrical descriptors shows the highest correlation coefficient, which indicates the binding factor of the compound. To evaluate the anticancer property molecular docking study of six selected ligands based on Andrews affinity were performed with nuclear factor-kappa protein kinase (Protein Data Bank ID 4G3D), which is an established therapeutic target for cancers. Along with QSAR study and docking result, it was predicted that bowsellic acid can also be treated as a potential anticancer compound.Conclusions:Along with QSAR study and docking result, it was predicted that bowsellic acid can also be treated as a potential anticancer compound.

Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review

“…The whole IAV genome codes for different proteins including NA (neuraminidase), RNA polymerases (PB1, PB2, and PA), HA, M1 (matrix proteins), M2 (ion channel), and NP (nucleoprotein) (Hutchinson, 2018). In silico studies targeting NA, PB2, HA, M1, and M2, as well as different signaling pathways (AKT1, TP53, MAPK1, and RELA) illustrated that curcumin and its different derivatives act as acceptable inhibitors of these proteins and pathways (Jayasree et al, 2014; Kim, Choi, Kim, Kang, & Kim, 2021b; Richart et al, 2018; Roy et al, 2021; Satpathy et al, 2012; Singh & Misra, 2012).…”

Boswelliaextrakte/Boswelliasäuren bei malignen Tumoren: Eine Übersicht

“…Dies führte zu Bemühungen vieler Autoren, Wirkungsstärke und Bioverfügbarkeit von Boswelliasäuren durch chemische Modifikationen zu verbessern [55][56][57][58]. Dazu zählen: die Verwendung von Boswelliasäuren in Form von Nanopartikeln, der Zusatz von Lösungsvermittlern oder die Synthese von wirksameren Analogen [59], wobei letztere bei einer Anzahl von Tumorzelllinien deren Proliferation hemmten und Apoptose aktivierten und dies bei einer IC 50 von 0,2 bei 0,6 µM.…”